Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 65,582
▼ 6% vs 2024
Profit
Healthy€ 16,399
▼ 17% vs 2024
Debts
Normal€ 449,903
▼ 10% vs 2024
GLOBIPHARM from Kontich, company number BE0843002254, closed financial year 2025 with a result of € 16,399 after tax. For that financial year GLOBIPHARM recorded a gross margin of € 65,582 and equity of € 90,837. Compared with financial year 2024, the result moved from € 19,641 to € 16,399. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 9, 2026.
What happened at GLOBIPHARM?
What happened at GLOBIPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 16,399 (▼ 17% vs 2024). Source: NBB ↗
- New establishment in Kontich. KBO
- Start of the company according to the CBE. KBO
In short
From € 46,346 profit in 2021 to € 16,399 profit in 2025.
Paid € 34,757 in corporate taxes since 2021.
Best year ever: 2021, with € 46,346 profit.
Paid out € 60,000 in dividends to the owners in total.
A new publication or filing at GLOBIPHARM? We notify you, reason included.
Follow GLOBIPHARMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind GLOBIPHARM are A-Pop Management CommV CommV and Swolfs Consultancy BV BV. The same people are also behind PHARMACEUTICAL ENTERPRISES BELGIUM and GLOBIFER INTL.
Directors
According to the 2025 annual accounts
Director · represented by Popowski Anthony
Also active at: PHARMACEUTICAL ENTERPRISES BELGIUM, GLOBIFER INTL
Director · represented by Swolfs Patrick
Also active at: PHARMACEUTICAL ENTERPRISES BELGIUM
Establishments
Establishment units
Physical locations of this company
Satenrozen 6A box 2
2550 Kontich
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
PHARMACEUTICAL ENTERPRISES BELGIUM same network
€ 53,524 gross margin · 2025
CADIS
€ 986,725 gross margin · 2025
Straalstudio
Schilderstudio
€ 887,895 gross margin · 2025
BJ BTW EENHEID
+8 more
Details
- Company number
- 0843.002.254
- VAT number
- BE 0843.002.254
- Registered office
- Satenrozen 6A bus 2, 2550 Kontich
- Names & denominations
- GLOBIPHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2012
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Groothandel in farmaceutische en medische artikelen